Back to search
FDAFDA · Food and drugs·Recall number D-0184-2023

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

Published February 1, 2023 · Recall initiated: December 22, 2022

Summary

FDA records drug Class I recall D-0184-2023, published February 1, 2023 and initiated December 22, 2022. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 89,700 vials; Lot: Lot: 33045BA, EXP 1SEP2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Glass particulate matter detected in injectable.

What to do

Voluntary: Firm initiated · Press Release

Get an email if VANCOMYCIN HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VANCOMYCIN HYDROCHLORIDE
Manufacturer
Pfizer Inc.
Distributor
USA nationwide and Puerto Rico
Lot
Lot: 33045BA, EXP 1SEP2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01 recalled?

Yes. FDA published recall D-0184-2023 on February 1, 2023. Reported hazard: Presence of Particulate Matter: Glass particulate matter detected in injectable.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VANCOMYCIN HYDROCHLORIDE.